Julia A. Haller, MD, ophthalmologist-in-chief at Wills Eye Hospital, has been named CEO, succeeding Joseph P. Bilson, ...

Latanoprostene bunod 0.024% significantly reduced IOP across patient groups and appeared well regarded among physicians and ...

Nicotine ingestions among young children declined 2015, but nicotine pouch ingestions more than 700% 2020, according to a ...

There was a lot of excitement when Tepezza became the first drug approved for the treatment of thyroid eye disease in January ...

One drop of Miebo had no significant impact on presurgical corneal measurements taken within 60 minutes of instillation, ...

Lyme disease is a complex condition with a long history of misdiagnosis, and Lyme arthritis, a late manifestation of the ...

A multi-ancestry polygenic risk score could help health care professionals predict a person’s risk for developing obesity ...

A 64-year-old woman presented to an outside provider with 5 days of left eye “burning, itching, redness and blurry vision” ...

Nephrology has added a number of new training positions to the field in recent years, but interest has not kept pace. A study ...

The FDA approved Anzupgo for the treatment of moderate to severe chronic hand eczema in adults who do not adequately respond ...

Long-acting lenacapavir has been shown to be a promising option for HIV PrEP and is now recommended globally by WHO, with a ...

A high dose of centanafadine was shown to be safe and effective at lowering ADHD symptoms for adolescents, according to ...